Recent Finacing
Recent Raise
Calithera Biosciences is a clinical-stage biopharma developing small-molecule oncology therapies (glutaminase, MCL-1, caspase modulators) and an arginase inhibitor (CB-280) for cystic fibrosis.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Calithera Biosciences.
